Global Women's Health Market 2017-2023 - Reproductive Health / Post Menopausal Health / Urological Disorders

DUBLIN, October 24, 2017 /PRNewswire/ --

The "Global Women's Health Market" report has been added to Research and Markets' offering.

The study presents a detailed analysis of the market dynamics and the estimation of the market size over the forecast period, 2017 to 2023.

The scope of this report is focused on the global Women's Health market, the different product segments, their marked trends and country wise analysis. In the report, 4 categories have been considered. The market value may vary from 5-7%, as the data have been collected from different sources at regional and country level.

The market analysis includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities and challenges) and industry analysis. The purpose of the study is to gain a holistic view of the women's health market in terms of various factors influencing it, such as, recent trends, technological advancements, and regulatory aspects of the market.

The scope of this report is centred upon conducting a detailed study of the solutions allied with the women's health market. The market has been segmented into product', application' and geographical regions'.

Key Topics Covered:

Executive Summary

1 Report Scope
1.1 Scope of the Report
1.2 Global Women's Health Market Segmentation
1.3 Key Learnings
1.4 Research Methodology

2 Market Overview

3 Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

4 Competitive Insights
4.1. Share of Key Developments & Strategies
4.1.1. Collaborations/ Partnerships/ Joint Ventures/ Licensing Agreements
4.1.2. Regulatory Approvals
4.1.3. Mergers and Acquisitions
4.1.4. Business Expansions and Product Acquisitions
4.1.5. Product Launches
4.1.6. Others

5 Industry Insights
5.1. Regulatory Scenario
5.2. Patent Landscape

6 Global Women's Health Market, by Application
6.1. Segmentation of Global Women's Health Market, by Application
6.2. Reproductive Health
6.2.1. Infertility
6.2.2. Endometriosis
6.2.3. Poly Cystic Ovarian Syndrome (PCOS)
6.2.4. Contraceptives
6.2.4.1. Method of Contraceptive And Effectiveness
6.2.4.2. Types of Contraceptives
6.3. Post Menopausal Health
6.3.1. Menopause
6.3.2. Post Menopausal Osteoporosis
6.4. Urological Disorders
6.4.1. Urinary Incontinence
6.4.2. Urinary Tract Infection
6.4.3. Others

7 Global Women's Health Market, by Product Type
7.1. Introduction
7.2. Devices
7.2.1. Intra Uterine Devices
7.2.2. Vaginal Rings
7.2.3 Implants
7.2.4. Female Condoms
7.3. Drugs
7.3.1. Drugs for Treatment of Menopause
7.3.2. Drugs for Treatment of Menopausal Hot Flashes
7.4. Pharmaceutical Pipeline

8 Global Women's Health Market, by Geography

9 Company Profiles

• Abbott Laboratories
• Agile THERAPEUTICS
• Allergan plc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Eli Lilly and Company
• Enteris BIOPHARMA, Inc
• Evestra, Inc
• FERRING PHARMACEUTICALS
• GEDEON RICHTER PLC
• GlaxoSmithKline Plc
• HRA Pharma
• JDS THERAPEUTICS,LLC
• NEUROCRINE BIOSCIENCES, INC.
• NOVEN Pharmaceuticals,Inc.
• Novartis International AG
• Novo Nordisk
• Pfizer Inc.
• Radius Health Inc.
• Teva Pharmaceuticals Industries Limited
• TherapeuticsMD, Inc.
• VALEANT Pharmaceuticals International Inc.
• VERTICAL PHARMACEUTICALS,LLC
• Veru HEALTHCARE

For more information about this report visit https://www.researchandmarkets.com/research/4q2q5m/global_womens

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]